Board Meetings for BAFNAPH

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
BAFNAPHBafna Pharmaceuticals Limited13 Aug 2024Financial ResultsTo consider and approve the Unaudited financial results for the period ended Jun 30, 2024
BAFNAPHBafna Pharmaceuticals Limited29 May 2024Financial ResultsTo consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2024
BAFNAPHBafna Pharmaceuticals Limited29 May 2024BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited12 Feb 2024Financial ResultsTo consider and approve the un-audited financial results for the period ended December 31, 2023
BAFNAPHBafna Pharmaceuticals Limited12 Feb 2024BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 12-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited09 Nov 2023Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023
BAFNAPHBafna Pharmaceuticals Limited09 Nov 2023BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited11 Aug 2023BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited11 Aug 2023Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2023
BAFNAPHBafna Pharmaceuticals Limited26 Jun 2023Other business mattersTo consider and approve the appointment of 1. Mr. Vinayak Dinesh Dendukuri (DIN: 07601309) as Additional Director designated as Whole-time Director Operation.2. Mr. Upendar Mekala Reddy (DIN: 08898174) as Additional Director designated as Non-Executive Non-independent Director;3. Mr. Krishna Yeachuri (DIN: 00066898) as Additional Director designated as Non-Executive Independent Director, and any other business with the permission of the Chair.
BAFNAPHBafna Pharmaceuticals Limited26 Jun 2023BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 26-Jun-2023 to consider Other business.Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited27 May 2023BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited24 May 2023BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation
BAFNAPHBafna Pharmaceuticals Limited24 May 2023Financial ResultsTo consider and approve the financial results for the period ended March 31, 2023
BAFNAPHBafna Pharmaceuticals Limited07 Apr 2023Other business mattersTo Consider The Appointment Of Company Secretary Cum Compliance Officer And Any Other Business With The Permission Of The Chair
Showing page 2 of 4 (46 total items)